A review of glycated albumin as an intermediate glycation index for controlling diabetes

Journal of Diabetes Science and Technology

Volumn 2, Issue 6, 2008, Pages 1114-1121

  Vernon Roohk, H ^a   Zaidi, Asad R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Epinex Diagnostics Inc   (United States)

Author keywords

Gestational diabetes; Glycated albumin; Glycation; Glycation index; Rapid assay; Type 2 diabetes

Indexed keywords

EID: 77649133503     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680800200620     Document Type: Review

References (44)

1. Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan D, Peterson CM, Sacks DB. Tests of glycemia in diabetes. Diabetes Care. 2004;27(7):1761-73.
2. Davis WA, Bruce DG, Davis TM. Does self-monitoring of blood glucose improve outcome in type-2 diabetes? The Fremantle Diabetes Study. Diabetologia. 2007;50(3):510-5.
3. Schütt M, Kern W, Krause U, Busch P, Dapp A, Grziwotz R, Mayer I, Rosenbauer J, Wagner C, Zimmermann A, Kerner W, Holl RW, DPV Initiative. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24, 500 patients from 191 centers in Germany and Austria. Exp Clin Endocrinol Diabetes. 2006;114(7):384-8.
4. Farmer A, Wade A, Goyder E, Yudkin P, French D, Craven A, Holman R, Kinmonth AL, Neil A. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomized trial. BMJ. 2007;335(7611):132.
5. Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan DM, Peterson CM, American Diabetes Association. Tests of glycemia in diabetes. Diabetes Care. 2003;26(Suppl):S106-8.
6. Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB. A new look at screening and diagnosing diabetes mellitus. J. Clin. Endocrinol Metab. 2008;93(7):2447-53.
7. Jeffcoate SL. Diabetes control and complications: the role of glycated hemoglobin, 25 years on. Diabet Med. 2004;21(7):657-65.
8. Buse JB, Freeman JL, Edelman SV, Jovanovic L, McGill JB. Serum 1, 5-anhydoglucitol (GlycoMark): a short-term glycemic marker. Diabetes Technol Ther. 2003;5(3):355-63.
9. Dungan KM, Buse JB, Largay J, Kelly MM, Button EA, Kato S, Wittlin S. 1, 5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes. Diabetes Care. 2006;29(6):1214-9.
10. Lyons TJ, Baynes JW, Patrick JS, Colwell JA, Lopes-Vierlla MF. Glycosylation of low density lipoprotein in patients with type 1 (insulin dependent) diabetes: correlations with other parameters of glycemic control. Diabetologia. 1986;29(10):685-9.
11. Edelman SV, Callahan P, Deeb LC. Multisite evaluation of a new diabetes self-test for glucose and glycated protein (fructosamine). Diabetes Technol Ther. 2000;2(2):233-8.
12. Carter AW, Borchardt N, Cooney M, Greene D. Dual-test monitoring of hyperglycemia using daily glucose and weekly fructosamine values. Diabetes Technol Ther. 2001;3(3):399-403.
13. Lindsey CC, Carter AW, Mangum S, Greene D, Richardson A, Brown S, McCandless B. A prospective, randomized, multicentered controlled trial to compare the annual glycemic and quality outcomes of patients with diabetes mellitus monitored with weekly fructosamine testing versus usual care: a 3-month interim analysis. Diabetes Technol Ther. 2002;4(5):637-42.
14. Carter AW, Borchardt N, Cooney M, Greene D. Dual test diabetes screening project: screening for poor glycemic control in a large workplace population. Diabetes Technol Ther. 2000;2(4):529-36.
15. Johnson RN, Baker JR. Inaccuracy in measuring glycated albumin concentration by thiobarbituric acid colorimetry and by boronate chromatography. Clin Chem. 1988;34(7):1456-9.
16. Cohen MP, Clements RS. Measuring glycated proteins: clinical and methodological aspects. Diabetes Technol Ther. 1999;1(1):57-70.
17. Silver AC, Lamb E, Cattell WR, Dawnay AB. Investigation and validation of the affinity chromatography method for measuring glycated albumin in serum and urine. Clin Chim Acta. 1991;202(1-2):11-22.
18. Kumar A, Rao P, Pattabiriman TN. A colorimetric method for the estimation of serum glycated proteins based on differential reduction of free and bound glucose by sodium borohydride. Biochem Med Metab Biol. 1988;39(3):296-304.
19. Mashiba S, Uchida K, Okuda S, Tomita S. Measurement of glycated albumin by the nitroblue tetrazolium colorimetric method. Clin Chim Acta. 1992;212(1-2):3-15.
20. Kobayashi K, Yoshimoto K, Hirauchi K, Uchida K. A novel colorimetric method for determination of glycated protein based on 2-keto-glucose release with hydrazine. Biol Pharm Bull. 1993;16(2):195-8.
21. Choi S, Choi EY, Kim DJ, Kim JH, Kim TS, Oh SW. A rapid, simple measurement of human albumin in whole blood using a fluorescence immunoassay (I). Clin Chim Acta. 2004;339(1-2):147-56.
22. Ikeda K, Sakamoto Y, Kawaski Y, Miyake T, Tanaka K, Urata T, Katayama Y, Ueda S, Horiuchi S. Determination of glycated albumin by enzyme-linked boronate immunoassay (ELBIA). Clin Chem. 1998;44(2):256-63.
23. Cohen MP. Caution: interpretation of results of HPLC assay for serum glycated albumin. Diabetologia. 1991;34(10):766.
24. Kouzuma T, Usami T, Yamakoshi M, Takahashi M, Imamura S. An enzymatic method for the measurement of glycated albumin in biological samples. Clin Chim Acta. 2002;324(1-2):61-71.
25. Kouzuma T, Uemastu Y, Usami T, Imamura S. Study of glycated amino acid elimination reaction for an improved enzymatic glycated albumin measurement method. Clin Chim Acta. 2004;346(2):135-43.
26. Yamaguchi M, Kambe S, Eto T, Yamakoshi M, Kouzuma T, Suzuki N. Point of care testing system via enzymatic method for the rapid efficient assay of glycated albumin. Biosens Bioelectron. 2005;21(3):426-32.
27. Gugliucci A. Glycation as the glucose link to diabetic complications. J Am Osteopath Assoc. 2000;100(10):621-34.
28. Pu LJ, Lu L, Shen WF, Zhang Q, Zhang RY, Zhang JS, Hu J, Yang Zk, Ding FH, Chen QJ, Shen J, Fang DH, Lou S. Increased serum glycated albumin level is associated with the presence and severity of coronary artery disease in type 2 diabetic patients. Circ J. 2007;71(7):1067-73.
29. Okumura A, Mitamura Y, Namekata K, Nakamura K, Harada C, Harada T. Glycated albumin induces activation of activator-protein-1 in retinal glial cells. Jpn J Ophthalmol. 2007;51(3):236-7.
30. Shuvaev VV, Laffont I, Serot JM, Fujii J, Taniguchi N, Siest G. Increased protein glycation in cerebrospinal fluid of Alzheimer's disease. Neurobiol Aging. 2001;22(3):397-402.
31. Moriyama K, Kanamoto N, Hataya Y, Nanbu T, Hosoda K, Arai H, Nakao K. A case of type 2 diabetes mellitus developing hypothyroidism discovered as a result of discrepancy between glycated hemoglobin and glycated albumin values. Diabetes Res Clin Pract. 2006;71(3):227-32.
32. Monier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295(14):1681-7.
33. Takahashi S, Uchino H, Shimizu T, Kanazawa A, Tamura Y, Sakai K, Watada H, Hirose T, Kawamori R, Tanaka Y. Comparison of glycated albumin (GA) and glycated hemoglobin (HbAlc) in type 2 diabetic patients: usefulness of GA for evaluation for short-term changes in glycemic control. Endocr J. 2007;54(1):139-44.
34. Hicks JM, Haeckel R, Price CP, Lewandrowski K, Wu AH. Recommendations and opinions for the use of point-of-care testing for hospitals and primary care: summary of a 1999 symposium. Clin Chim Acta. 2001;303(1-2):1-17.
35. Inaba M, Okuno S, Kumeda Y, Yamada S, Imanishi Y, Tabata T, Okamura M, Okada S, Yamakawa T, Ishimura E, Nishizawa Y, Osaka CKD Expert Research Group. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephrol. 2007;18(3):896-903.
36. Peacock TP, Shihabi ZK, Bleyer AJ, Dolbare EL, Byers JR, Knovich MA, Calles-Escandon J, Russell GB, Freedman BI. Comparison of glycated albumin and hemoglobin A (lc) in diabetic subjects on hemodialysis. Kidney Int. 2008;73(9):1062-8.
37. Baker JR, O'Connor JP, Metcalf PA, Lawson MR, Johnson RN. Clinical usefulness of estimation of serum fructosamine concentration as a screening test for diabetes mellitus. Br Med J (Clin Res Ed). 1983;287(6396):863-7.
38. Shima K, Abe F, Chikakiyo H, Ito N. The relative value of glycated albumin, hemoglobin Ale and fructosamine when screening for diabetes mellitus. Diabetes Res Clin Pract. 1989;7(4):243-50.
39. Guillausseau PJ, Charles MA, Paolaggi F, Timsit J, Chanson P, Peynet J, Godard V, Eschwege E, Rousselet F, Lubetzki. Comparison of HbAl and fructosamine in diagnosis of glucose-tolerance abnormalities. Diabetes Care. 1990;13(8):898-900.
40. Tsuji I, Nakamoto K, Hasegawa T, Hisashige A, Inawashiro H, Fukao A, Hisamichi S. Receiver operating characteristic analysis on fasting plasma glucose, HbAlc, and fructosamine on diabetes screening. Diabetes Care. 1991;14(11):1075-7.
41. Kasezawa N, Kiyose H, Ito K, Iwatsuka T, Kawai H, Goto Y, Kondo K, Sasamori N, Suzuki K, Suzuki T. Criteria for screening diabetes mellitus using serum fructosamine level and fasting plasma glucose level. The Japanese Society of Multiphasic Health Testing and Services (JMHT), Fructosamine Working Committee. Methods Inf Med. 1993;32(3):237-40.
42. Cefalu WT, Ettinger WH, Bell-Farrow AD, Rushing JT. Serum fructosamine as a screening test for diabetes in the elderly: a pilot study. J Am Geriatr Soc. 1993;41(10):1090-4.
43. Narayanan S. Laboratory monitoring of gestational diabetes. Ann Clin Lab Sci. 1991;21(6):392-401.
44. Carter AW. Home fructosamine testing: is its demise premature? Diabetes Technol Ther. 2002;4(5):643-4.